What Happened?
New York, NY-based Renalytix Resigned Trent Bingham as Chief Human Resources Officer
About the Company
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is the global founder and leader in the new field of bioprognosisTM for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company`s lead product, KidneyIntelX, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
About the Person
Trent D. Bingham is Chief Human Resources Officer at Renalytix. Previously, Trent held various senior HR leadership roles in the industry.
Info Source
News
Short Profile